Online Bayesian optimization of vagus nerve stimulation.

Bayesian optimization nerve stimulation neuromodulation therapy vagus nerve

Journal

Journal of neural engineering
ISSN: 1741-2552
Titre abrégé: J Neural Eng
Pays: England
ID NLM: 101217933

Informations de publication

Date de publication:
13 Mar 2024
Historique:
medline: 14 3 2024
pubmed: 14 3 2024
entrez: 13 3 2024
Statut: aheadofprint

Résumé

In bioelectronic medicine, neuromodulation therapies induce neural signals to the brain or organs, modifying their function. Stimulation devices capable of triggering exogenous neural signals using electrical waveforms require a complex and multi-dimensional parameter space to control such waveforms. Determining the best combination of parameters (waveform optimization or dosing) for treating a particular patient's illness is therefore challenging. Comprehensive parameter searching for an optimal stimulation effect is often infeasible in a clinical setting due to the size of the parameter space. Restricting this space, however, may lead to suboptimal therapeutic results, reduced responder rates, and adverse effects.

Approach. As an alternative to a full parameter search, we present a flexible machine learning, data acquisition, and processing framework for optimizing neural stimulation parameters, requiring as few steps as possible using Bayesian optimization. This optimization builds a model of the neural and physiological responses to stimulations, enabling it to optimize stimulation parameters and provide estimates of the accuracy of the response model. The vagus nerve innervates, among other thoracic and visceral organs, the heart, thus controlling heart rate, making it an ideal candidate for demonstrating the effectiveness of our approach.

Main results. The efficacy of our optimization approach was first evaluated on simulated neural responses, then applied to vagus nerve stimulation intraoperatively in porcine subjects. Optimization converged quickly on parameters achieving target heart rates and optimizing neural B-fiber activations despite high intersubject variability. 

Significance. An optimized stimulation waveform was achieved in real time with far fewer stimulations than required by alternative optimization strategies, thus minimizing exposure to side effects. Uncertainty estimates helped avoiding stimulations outside a safe range. Our approach shows that a complex set of neural stimulation parameters can be optimized in real-time for a patient to achieve a personalized precision dosing. &#xD.

Identifiants

pubmed: 38479016
doi: 10.1088/1741-2552/ad33ae
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 IOP Publishing Ltd.

Auteurs

Lorenz Wernisch (L)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Tristan Edwards (T)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Antonin Berthon (A)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Olivier Tessier-Lariviere (O)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Elvijs Sarkans (E)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Myrta Stoukidi (M)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Pascal Fortier-Poisson (P)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Max Pinkney (M)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Michael Thornton (M)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Catherine Hanley (C)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Susannah Lee (S)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Joel Jennings (J)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Ben Appleton (B)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Philip Garsed (P)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Bret Patterson (B)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Will Buttinger (W)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Samuel Gonshaw (S)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Matjaz Jakopec (M)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Sudhakaran Shunmugam (S)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Jorin Mamen (J)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Aleksi Tukiainen (A)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Guillaume Lajoie (G)

Dept. de Mathématiques et Statistiques, University of Montreal, 2920 chemin de la Tour, Montreal, Quebec, H3T 1J4, CANADA.

Oliver Armitage (O)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Emil Hewage (E)

Bios Health Ltd, 72 Hills Road, Cambridge, CB2 1LA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Classifications MeSH